In a major step forward for blood pressure treatment, the US Food and Drug Administration (FDA) has approved WIDAPLIK, a new ...

June 11, 2025 – The FDA has approved a new pill for adults with high blood pressure (hypertension) that combines three medicines in one.Available in one regular and two lower doses, it offers a ...

The GMRx2 pill, which was developed by the pharmaceutical company George Medicines, contains the blood pressure meds telmisartan, amlodipine and indapamide. It’s taken once daily.

High blood pressure is a significant global health burden, affecting 300 million people in India and nearly half of all U.S. adults. Current international hypertension guidelines suggest combining ...

A groundbreaking development in hypertension treatment has emerged from the University of South Wales, offering new hope for the 1.28 billion adults worldwide affected by high blood pressure.

When large populations are studied, the people with blood pressures of 110/70 or less have the healthiest arteries—which ...

Novel low-dose 3-in-1 blood pressure pill significantly outperforms standard care, study shows Over 80% of patients achieved control within a month, sustained at six months ...

Single-pill combinations of three or more antihypertensive drugs are the way forward to help patients reach lower blood pressure targets, according to experts evaluating the approach.

Two-medication combo pill lowered blood pressure among adults in India American Heart Association Scientific Sessions 2024, Late Breaking Science Abstract 4166995 ...

Repurposing amlodipine, a well-established blood pressure medication, offers a promising and swift pathway to address ADHD symptoms. Our research indicates that, due to its existing approval and ...

WIDAPLIK™, a newly FDA-approved triple combo pill, promises better blood pressure control for adults, including those starting hypertension treatment for the first time.